HYUNDAI BIOLAND Co.,Ltd. (KOSDAQ:052260)
South Korea · Delayed Price · Currency is KRW 3,500.00
+270.00 (8.36%)
At close: Aug 3, 2026
HYUNDAI BIOLAND Market Cap
HYUNDAI BIOLAND has a market cap or net worth of 96.9 billion as of August 3, 2026. Its market cap has decreased by -34.22% in one year.
Market Cap
96.90B
Enterprise Value
86.11B
Revenue
135.04B
Ranking
n/a
PE Ratio
7.77
Stock Price
3,500.00
ChartMarket Cap Chart
Since March 1, 2002, HYUNDAI BIOLAND's market cap has increased from 25.40B to 96.90B, an increase of 281.45%. That is a compound annual growth rate of 5.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 96.90B | -24.80% |
| Dec 30, 2025 | 128.85B | -4.87% |
| Dec 30, 2024 | 135.45B | -9.52% |
| Dec 28, 2023 | 149.70B | -25.80% |
| Dec 29, 2022 | 201.75B | -21.80% |
| Dec 30, 2021 | 258.00B | -29.65% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PHARMARESEARCH BIO | 130.44B |
| Ahn-Gook Pharmaceutical | 116.04B |
| High Tech Pharm | 113.56B |
| DongKoo Bio & Pharma | 103.98B |
| OPTUS Pharmaceutical | 96.35B |
| H.PIO | 87.82B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 85.27B |
| Daehan Nupharm | 78.60B |